We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
IMMATERIAL TO INNOVATION: THE STORY OF ARIAD PHARMACEUTICALS, INC. V. ELI LILLY & CO.
- Authors
Kimmelblatt, Brian
- Abstract
The article focuses on Ariad Pharmaceuticals Inc. v. Eli Lilly & Co., a U.S. Federal Circuit case regarding biotechnology patent. It discusses the effectivity of the resources and measures of biotechnology companies and universities to promote and enhance innovation. A brief overview of patent scope theories is presented. It explores the impact of claim drafting on innovation and highlights the written description requirement.
- Subjects
UNITED States; BIOTECHNOLOGY patents; WRITTEN description requirement (Patent law); BIOTECHNOLOGY industry laws; ELI Lilly &; Co.; ARIAD Pharmaceuticals Inc.; ACTIONS &; defenses (Law)
- Publication
Brooklyn Journal of Corporate, Financial & Commercial Law, 2011, Vol 5, Issue 2, p503
- ISSN
1934-2497
- Publication type
Article